John Sarantopoulos
- Oncology top 2%
- Cancer Treatment and Pharmacology 37
- Colorectal Cancer Treatments and Studies 16
- Pancreatic and Hepatic Oncology Research 14
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 20
- Cancer Genomics and Diagnostics 12
- Molecular Biology top 5%
- Genetics top 5%
- Immunology top 5%
-
- Lung Cancer Treatments and Mutations 18
-
- Radiopharmaceutical Chemistry and Applications 14
-
- Microtubule and mitosis dynamics 11
- Co-authors
- Devalingam MahalingamAlain C. MitaMonica MitaAnthony W. TolcherTyler J. CurielKamalesh K. SankhalaFrancis J. GilesJordi Rodón
- Journals
- Journal of Clinical Oncology (56 papers)Cancer Chemotherapy and Pharmacology (16 papers)Molecular Cancer Therapeutics (13 papers)
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
John Sarantopoulos
141 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 1.3k
- Cancer Research 382
- Molecular Biology 1.6k
- Genetics 238
- Immunology 443
Countries citing papers authored by John Sarantopoulos
This map shows the geographic impact of John Sarantopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Sarantopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Sarantopoulos more than expected).
Fields of papers citing papers by John Sarantopoulos
This network shows the impact of papers produced by John Sarantopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Sarantopoulos. The network helps show where John Sarantopoulos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Sarantopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 18 | |
| 3 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumorsbreakdown → | 2021 | 257 |
| 4 | 2021 | 20 | |
| 5 | 2020 | 49 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 47 | |
| 8 | 2017 | 68 | |
| 9 | 2017 | 6 | |
| 10 | 2015 | 139 | |
| 11 | 2014 | 187 | |
| 12 | 2014 | 24 | |
| 13 | 2014 | 241 | |
| 14 | 2014 | 3 | |
| 15 | 2014 | 8 | |
| 16 | 2012 | 30 | |
| 17 | 2012 | 70 | |
| 18 | 2011 | 35 | |
| 19 | A phase I and pharmacokinetic study of a CanAg-targeted immunoconjugate, HuC242-DM4, in patients with CanAg-expressing solid tumors | 2007 | 2 |
| 20 | A phase I and pharmacokinetic (PK) study of vinorelbine liposomes injection in patients with advanced solid tumors, non-Hodgkin’s lymphoma, and Hodgkin’s disease | 2007 | 1 |
About John Sarantopoulos
John Sarantopoulos is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 143 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (37 papers), Cancer, Hypoxia, and Metabolism (20 papers), Lung Cancer Treatments and Mutations (18 papers), Colorectal Cancer Treatments and Studies (16 papers), Radiopharmaceutical Chemistry and Applications (14 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cancer Genomics and Diagnostics (12 papers) and Microtubule and mitosis dynamics (11 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (382 citations) and Molecular Biology (1.6k citations). John Sarantopoulos has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Devalingam Mahalingam, Alain C. Mita, Monica Mita, Anthony W. Tolcher, Tyler J. Curiel, Kamalesh K. Sankhala, Francis J. Giles, Jordi Rodón, Chia‐Chi Lin and Andrew Brenner. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Molecular Cancer Therapeutics, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.